Pediatrics in Review Note to Institutions for Site Subscriptions
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gartner, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gartner, L. M.

Neonatal Jaundice

Lawrence M. Gartner MD1
 1 Professor, Department of Pediatrics, The University of Chicago, and Wyler Children's Hospital, Chicago, IL.

Jaundice in the newborn has presented a diagnostic challenge to clinicians for millennia. Because virtually every newborn infant has an elevated serum bilirubin in comparison with the normal adult and more than 50% are visibly jaundiced during the first week of life, the physician's first challenge is to differentiate pathology from variations within the normal range. Today, clinicians are faced with critical therapeutic decisions as well; treatment should be instituted only when benefit will accrue. During the past several years, clinical experts and scholars have reconsidered the risks and possible benefits of bilirubin in the newborn, have altered indications for diagnostic procedures, and have suggested new criteria for therapy. In addition, the relationship between breastfeeding and neonatal jaundice has been clarified. These major new concepts have changed the management of jaundice in the newborn significantly, particularly in the healthy term infant. This review examines these new concepts, places them in a clinical perspective, and provides guidelines for management based on a synthesis of expert opinions and the recently published practice guidelines of the American Academy of Pediatrics. 1

Definitions

The term neonatal jaundice designates all situations in the newborn infant in which the serum bilirubin is sufficiently elevated to cause at least minimally visible yellowing of the skin, ocular sclerae, or both.




This article has been cited by other articles:


Home page
 PediatricsHome page
L. M. Gartner, C. T. Herrarias, and R. H. Sebring
Practice Patterns in Neonatal Hyperbilirubinemia
Pediatrics, January 1, 1998; 101(1): 25 - 31.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics Pediatrics in Review
Copyright © 1994 by the American Academy of Pediatrics.